Skip to main content

Table 4 Differentially methylated regions in blood

From: Alzheimer’s disease-associated (hydroxy)methylomic changes in the brain and blood

Gene

Position

Gene feature

n

p value

Šidák P

Average Δ% (range Δ%)

Baseline

 LDLRAD4

chr18:13611370-13611825

TSS; Exon; 5′UTR; Intron

7 (7 up; 0 down)

3.25E−11

2.88E−08

3.64 (2.54:5.14)

 ZNF154

chr19:58220080-58220838

TSS; Intron; 5′UTR; CDS; Exon

11 (11 up; 0 down)

1.16E−09

6.16E−07

3.87 (1.75:5.11)

 PRRT1

chr6:32116216-32117402

Intron; 3′UTR; CDS

26 (24 up; 2 down)

2.61E−09

8.85E−07

1.77 (− 3.1:5.37)

 SYMPK; RSPH6A

chr19:46318514-46319399

Intron; 3′UTR; CDS; TSS; Exon; 5′UTR

7 (7 up; 0 down)

6.18E−09

2.81E−06

3.2 (2.07:4.87)

 TENM3

chr4:183728549-183729462

Intergenic

5 (5 up; 0 down)

1.02E−08

4.48E−06

2.69 (− 0.67:4.25)

 GLIPR1L2; CAPS2

chr12:75784617-75785296

TSS; Intron; 5′UTR; CDS; Exon

10 (10 up; 0 down)

2.36E−07

1.40E−04

2.72 (1.85:4.5)

 GPR35

chr2:241562085-241562758

Intron

6 (6 up; 0 down)

3.16E−07

1.89E−04

3.83 (3.35:4.37)

 ZMAT2

chr5:140079591-140080246

TSS; Intron; 5′UTR; CDS

10 (9 up; 1 down)

3.86E−07

2.37E−04

1.21 (− 1.35:2.81)

 ZNF649-AS1; ZNF577

chr19:52390810-52391368

Exon; TSS; Intron; 5′UTR

10 (10 up; 0 down)

7.42E−07

5.35E−04

5.11 (2.93:6.61)

 ULK1

chr12:132380696-132380904

Intron

3 (3 up; 0 down)

3.57E−07

6.90E−04

2.1 (0.92:3.5)

 SLC44A4

chr6:31846769-31847029

TSS; Exon; 5′UTR

8 (0 up; 8 down)

4.61E−07

7.13E−04

− 1.14 (− 3.86:2.41)

 OXT

chr20:3051954-3052484

TSS; Intron; 5′UTR; CDS

10 (9 up; 1 down)

9.41E−07

7.14E−04

3.43 (− 0.45:6.79)

 FAM222A

chr12:110156245-110156460

Intron; 5′UTR

4 (4 up; 0 down)

2.85E−06

5.33E−03

3.11 (2.66:3.43)

 CYBRD1

chr2:172430723-172430817

Intergenic

3 (0 up; 3 down)

1.83E−06

7.78E−03

− 1.75 (− 2.7:− 0.26)

 RUNX2

chr6:45391852-45391974

Intron

3 (3 up; 0 down)

5.11E−06

1.67E−02

3.19 (0.74:4.53)

Follow-up

 GSDMD

chr8:144635309-144635611

TSS; Exon; 5′UTR

5 (0 up; 5 down)

7.08E−18

9.43E−15

− 0.68 (− 1.53:− 0.25)

 IRGC

chr19:44203583-44203914

Intergenic

3 (0 up; 3 down)

2.40E−12

2.92E−09

0.87 (− 0.32:1.53)

 LINC01149

chr6:31409319-31409758

Exon

12 (0 up; 12 down)

3.03E−10

2.78E−07

− 0.96 (− 2.17:− 0.12)

 RUFY1

chr5:178986131-178986907

TSS; Exon; 5′UTR; Intron

9 (9 up; 0 down)

3.77E−09

1.96E−06

2.85 (1.3:4.19)

 GLIPR1L2; CAPS2

chr12:75784541-75785296

TSS; Intron; 5′UTR; CDS; Exon

11 (11 up; 0 down)

1.30E−08

6.94E−06

1.34 (0.64:2.81)

 RAD51B; LOC100996664

chr14:69095057-69095680

Intron; Exon

5 (5 up; 0 down)

3.57E−08

2.31E−05

6.05 (4.89:7.1)

 LOC105372397; MAP4K1

chr19:39086733-39087768

Intron; Exon; CDS

5 (4 up; 1 down)

8.14E−08

3.17E−05

− 0.28 (− 1.05:0.3)

 KHDRBS2

chr6:62996022-62996703

Exon; TSS; 5′UTR

11 (11 up; 0 down)

6.92E−08

4.09E−05

1.25 (0.69:1.89)

 STAG3L5P-PVRIG2P-PILRB; STAG3L5P; PMS2P1

chr7:99933717-99933798

Exon

3 (3 up; 0 down)

1.01E−08

5.02E−05

0.16 (− 0.01:0.45)

 ISOC2

chr19:55972646-55973339

TSS; Intron; Exon; 5′UTR

9 (9 up; 0 down)

8.68E−08

5.04E−05

1.52 (0.78:2.51)

 RARRES2

chr7:150037988-150038599

Intron; 5′UTR

3 (0 up; 3 down)

1.63E−07

1.07E−04

0.71 (− 0.64:2.19)

 LINC01169

chr15:66947171-66947618

Intron

5 (0 up; 5 down)

1.54E−07

1.39E−04

− 2.24 (− 5.41:− 0.83)

 TRAM1L1

chr4:118006405-118007226

TSS; CDS

11 (10 up; 1 down)

9.95E−07

4.88E−04

1.14 (− 0.81:2.96)

 LDHC

chr11:18433500-18434016

TSS; Intron; Exon; 5′UTR

7 (7 up; 0 down)

6.92E−07

5.40E−04

2.76 (− 0.3:4.7)

 ZNF337-AS1; NANP

chr20:25604462-25605179

Intron; Exon; TSS; 5′UTR; CDS

12 (12 up; 0 down)

1.10E−06

6.18E−04

0.4 (− 0.27:1.36)

 IFT74; IFT74-AS1

chr9:26956236-26956770

Intron; 5′UTR; TSS; Exon

3 (2 up; 1 down)

8.65E−07

6.52E−04

0.21 (− 0.2:0.52)

 MIR3659

chr1:38599626-38600200

Intergenic

4 (0 up; 4 down)

1.34E−06

9.38E−04

− 0.49 (− 1.35:0.64)

 LINC01983

chr3:195578011-195578281

Intron

6 (0 up; 6 down)

6.38E−07

9.51E−04

− 0.07 (− 0.76:0.67)

 HEXD

chr17:80393124-80393667

Intron; CDS

5 (5 up; 0 down)

1.89E−06

1.40E−03

− 0.52 (− 2.54:0.39)

 GNG7

chr19:2543602-2544101

Intron; 5′UTR

5 (5 up; 0 down)

5.29E−06

4.26E−03

1 (0.25:1.95)

 F11-AS1

chr4:187422005-187422120

Exon

5 (5 up; 0 down)

1.66E−06

5.81E−03

1.26 (0.4:1.87)

  1. Differentially methylated regions in the comparisons of Alzheimer’s disease converters and non-converters, prior to conversion at baseline (converters n = 54, non-converters n = 42), and after conversion at follow-up (converters n = 41, non-converters n = 42). Displayed for each region is the UCSC gene name, chromosomal position (genome build 37), gene feature (TSS, transcription start site; 5′UTR, 5′ untranslated region; CDS, coding sequence), number of probes in region and number of upregulated and downregulated probes (n), p value and multiple testing-corrected p (Šidák P), and average change in beta value (Alzheimer’s disease converter - control), including the range of the probe differences